Treatment and Management of HIV Infection in the United States

Session 2

March 21-23, 2013
Sheraton Downtown Hotel
Denver, CO, US
www.ACTHIV.org

Saturday, May 16, 2009 - 9:00 am - 12:00 pm

 

Session Co-Chairs: Dr. Paul Volberding, MD, San Francisco VA Medical Center
Doug Ward, MD, Dupont Circle Physicians Group



Session Objective(s):

Address the difficulties of caring for treatment experienced patients with HIV, including dealing with drug-resistant virus, and the complications of long-term treatment.

Incorporate approaches to maximize patient adherence with therapy and the reduction of viral transmission based on an understanding of the benefits of treatment.

Session Outline:


9:00 am – 9:45 am

Care of the treatment experienced patient

  •  Major review of strategies for treatment experienced patients specifically addressing drug resistance
  • Review of treatment toxicity as it influences later regimen redesign and the incorporation of newer agents

Speaker: Harry Lampiris, MD, San Francisco VA Medical Center

   

9:45 am – 10:15 am

Adherence

  • Strategies to support long term ARV adherence

Speaker: David Bangsberg, MD, Harvard University
   

10:15 am – 10:45 am

Treatment as Prevention

  • PEP, PREP and ARV/viral load/transmission

Speaker: Kenneth Mayer, MD, Brown University
   
10:45 am – 11:00 am BREAK
   
11:00 am – 12:00 pm Interactive Session Panel
Speakers: Kenneth Lichtenstein, MD, University of Colorado at Denver and Health Sciences Center; Doug Ward, MD; Paul Volberding, MD; Harry Lampiris, MD